Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients
Background. Hypertension is one of the leading causes of cardiovascular mortality. Although the pathogenetic process involved is not yet fully understood, the disease involves endothelial damage and inflammation. Calprotectin is an inflammatory marker that rises in parallel with disease activity in...
Saved in:
Main Authors: | Nergiz Bayrakci, Gülsüm Ozkan, Sonat Pinar Kara, Ahsen Yilmaz, Savas Guzel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | International Journal of Hypertension |
Online Access: | http://dx.doi.org/10.1155/2022/6912502 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum calprotectin in nonsegmental vitiligo: a possible marker of disease activity
by: Dalia A. Bassiouny, et al.
Published: (2025-01-01) -
Serum Calprotectin: A Potential Biomarker for Neonatal Sepsis
by: Lidia Decembrino, et al.
Published: (2015-01-01) -
Identifying Drug Prescription in Newly Diagnosed Hypertension Patients in India
by: Thomas Alexander, et al.
Published: (2025-01-01) -
Serum Calprotectin: An Antimicrobial Peptide as a New Marker For the Diagnosis of Sepsis in Very Low Birth Weight Newborns
by: Gianluca Terrin, et al.
Published: (2011-01-01) -
Fecal Calprotectin Use in Inflammatory Bowel Disease and Beyond: A Mini-Review
by: Bashaar Alibrahim, et al.
Published: (2015-01-01)